James Cavanaugh

James Cavanaugh

Directeur/Bestuurslid bij
SkinMedica, Inc.

Vermogen: 190 928 $ op 31-05-2026

89 jaar
Health Technology
Commercial Services
Finance

Profiel

James H.
Cavanaugh
is currently Director at Diacrin, Inc. (Delaware) and SkinMedica, Inc., Managing Director & Partner at HealthCare Ventures LLC since 1989, and Trustee at the Gerald R.
Ford Presidential Foundation.
Former positions include Non-Executive Chairman at Shire Plc, Chairman at Diversa Corp., Vicuron Pharmaceuticals LLC, CardioKine, Inc., The Richard Nixon Foundation, and Shire Acquisition, Inc. (1999–2008).
Chairman at Verenium Corp.
(1992–2013).
Director roles at MedImmune LLC (2007), Middlebrook Pharmaceuticals, Inc. (1999–2010), PharmAthene, Inc. (2007–2011), Colorescience Corp., Unihealth America, Inc., Marine National Bank (Irvine, California) as Founding Director, Nixon Group, Senseonics, Inc., Xanodyne Pharmaceuticals, Inc., Orqis Medical Corp., Healthcare Acquisition Corp., National Venture Capital Association, Pharmaceutical Research & Manufacturers Association, Consumer Healthcare Products Association, and Cypherpunk Technologies, Inc. (Independent Director, 2016–2026).
Deputy Director at Domestic Policy Council.
President at Smithkline Beckman Corp, Smithkline & French Laboratories US, Inc. (1985–1989), Smithkline Clinical Laboratories (1981–1985), French Laboratories U.S., Inc. (1989), Allergan Sales LLC, and Allergan International.
Deputy Assistant Secretary at US Department of Health & Human Services.
Trustee at The National Center for Genome Resources.
Education includes undergraduate degree from Fairleigh Dickinson University (1959), graduate degree from the University of Iowa (1961), and doctorate from the University of Iowa (1964).

Bekende belangen in openbare bedrijven

OndernemingDatumAantal aandelenTotale waardeWaarderingsdatum
20-04-2026 168.963 ( 0,16% ) 190 928 $ 31-05-2026

Actieve functies van James Cavanaugh

BedrijvenFunctieBegin
Private Equity Investor 01-01-1989
Directeur/Bestuurslid -
Directeur/Bestuurslid -
Directeur/Bestuurslid -

Eerdere bekende functies van James Cavanaugh

BedrijvenFunctieEinde
CYPHERPUNK TECHNOLOGIES INC. Directeur/Bestuurslid 18-06-2026
VERENIUM CORP Voorzitter 31-10-2013
Directeur/Bestuurslid 25-04-2011
Directeur/Bestuurslid 20-03-2010
Voorzitter 23-05-2008
Ervaring van James Cavanaugh in detail bekijken

Opleiding van James Cavanaugh

Ervaring
Beklede functies

Actief

Inactief

Beursgenoteerde bedrijven

Bedrijven in privébezit

Connecties

78

Eerstegraads connecties

38

Bedrijven verbonden in de eerste graad

Man

Vrouw

Besturend

Uitvoerend

Verwante bedrijven

Bedrijven in privébezit38

Health Technology

Health Technology

Commercial Services

Commercial Services

Health Technology

Health Technology

Health Technology

Distribution Services

Health Technology

Health Technology

Retail Trade

Finance

Finance

Finance

Commercial Services

Health Technology

Consumer Services

Consumer Services

Electronic Technology

Health Technology

Health Services

Finance

Government

Government

Commercial Services

Commercial Services

Pharmaceutical Research & Manufacturers Association

Commercial Services

Commercial Services

Health Technology

Health Technology

Commercial Services

Smithkline & French Laboratories US, Inc.

Smithkline Clinical Laboratories

Distribution Services

French Laboratories U.S., Inc.

Health Technology

Health Technology

  1. Beurs
  2. Insiders
  3. James Cavanaugh